Latest Market News

Osmond Resources has extended the known strike of critical mineral-bearing quartzite layers at its Orión Project in Spain through successful step-out drilling, setting the stage for upcoming assay results and resource evaluation.

TrivarX has reported promising interim results from its US veteran-focused mental health trial using ECG technology, while progressing a strategic acquisition of novel brain tumor imaging IP to broaden its diagnostic portfolio.

Endeavour Group’s first quarter results reveal a strong Hotels segment growth of 4.4%, alongside a retail sales recovery that returned to positive territory in September. Online sales surged by 20.9%, highlighting shifting consumer habits.

Farm Pride Foods reported a solid $3.58 million net operating cash inflow for the September quarter, despite ongoing pricing pressures. The company is investing in operational upgrades and has commenced construction of a large new hen rearing farm in Victoria.

Mammoth Minerals has completed key US gold project acquisitions and launched exploration drilling, backed by a $5 million capital raise and strategic board appointments.

IMEXHS Limited reported a 9% rise in Q3 FY25 revenue and a positive swing to $0.6m underlying EBITDA, reaffirming full-year guidance. Key contract wins and AI-driven efficiencies underpin margin gains despite political uncertainties in Colombia.

Holista Colltech reported improved cash flow management and robust growth in its dietary supplements division for 3QFY25, while navigating ongoing legal challenges with ProImmune.

Catapult Sports has completed its acquisition of IMPECT GmbH, a leader in soccer scouting analytics, enhancing its technology suite with proprietary data insights.

WA Kaolin Limited has reported a remarkable surge in sales volumes and revenue for the September 2025 quarter, driven by operational upgrades and expanding market reach. The company’s forward orders and product diversification signal robust growth ahead.

Equity Story Group reports a strong quarter for its Growth Fund but faces setbacks with the termination of the Baker Young acquisition. The company is now pursuing a significant capital raise and has restructured its board to drive future growth.

AVADA Group Limited reported a revenue increase in Q1 FY26 despite ending a major contract, alongside a significant reduction in operating cash outflows and ongoing debt repayments.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.